Andelyn Biosciences
Pre-clinicalAndelyn Biosciences is a gene therapy CDMO with deep expertise and experience in the development and production of viral vectors.
Founded
2020
Focus
Gene TherapyCell Therapy
About
Andelyn Biosciences is a gene therapy CDMO with deep expertise and experience in the development and production of viral vectors.
Funding History
2Total raised: $59.5M
Series A$55MDrive CapitalJun 15, 2021
Grant$4.5MNational Institute of Neurological Disorders and StrokeAug 15, 2020
Company Info
TypePrivate
Founded2020
LocationColumbus, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile